Application 211390
- Type
- ANDA
- Sponsor
- AIZANT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZILEUTON | ZILEUTON | TABLET, EXTENDED RELEASE;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211390-001 | ZILEUTON | ZILEUTON | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-10-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211390-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211390-001 | ZILEUTON | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-10-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A211390-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYFLO | ZILEUTON | Chiesi USA, Inc. | aee65202-fddb-497f-9f11-17cc727cb157 | 2025-11-30 | Warnings, Adverse reactions | ZILEUTON |
| Zileuton | ZILEUTON | Rising Pharma Holdings, Inc. | fd382540-b390-4e86-a94a-988ea89c93a8 | 2024-05-15 | Warnings, Adverse reactions | Zileuton ZILEUTON |
| Zileuton | ZILEUTON | NorthStar RxLLC | bc29c998-1324-46aa-8386-e5b2fc9e0b16 | 2024-05-02 | Warnings, Adverse reactions | Zileuton ZILEUTON |
| Zileuton | ZILEUTON | Golden State Medical Supply, Inc. | f7573809-7741-04c9-e053-6294a90ab193 | 2023-03-20 | Warnings, Adverse reactions | Zileuton ZILEUTON |
| Zileuton | ZILEUTON | Camber Pharmaceuticals, Inc. | 94313e24-9534-4b6c-b374-c436c4916303 | 2022-10-14 | Warnings, Adverse reactions | Zileuton ZILEUTON |
| Zileuton | ZILEUTON | Strides Pharma Science Limited | a826d16f-df07-447b-b050-b9a02ea1f89e | 2022-07-29 | Warnings, Adverse reactions | Zileuton ZILEUTON |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69339-130 | Zileuton | zileuton | DASH Pharmaceutical LLC | ANDA | Current |
| 69339-130 | Zileuton | zileuton | DASH Pharmaceutical LLC | ANDA | Current |
| 69339-130 | Zileuton | zileuton | DASH Pharmaceutical LLC | ANDA | Current |
| 69339-130 | Zileuton | zileuton | DASH Pharmaceutical LLC | ANDA | Current |